2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults-Reference-Cited by-同舟云学术

2022 Canadian Cardiovascular Society Guideline for Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors for Cardiorenal Risk Reduction in Adults

Published:2022-08 Issue:8 Volume:38 Page:1153-1167
ISSN:0828-282X
Container-title:Canadian Journal of Cardiology
language:en
Short-container-title:Canadian Journal of Cardiology

Author:

Mancini G.B. John,O’Meara Eileen,Zieroth Shelley,Bernier Mathieu,Cheng Alice Y.Y.,Cherney David Z.I.,Connelly Kim A.,Ezekowitz Justin,Goldenberg Ronald M.,Leiter Lawrence A.,Nesrallah Gihad,Paty Breay W.,Piché Marie-Eve,Senior Peter,Sharma Abhinav,Verma Subodh,Woo Vincent,Darras Pol,Gabor Jonathan Y.,Grégoire Jean,Lonn Eva,Stone James A.,Yale Jean-François,Yeung Colin,Zimmerman Deborah

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference60 articles.

1. Diabetes for cardiologists: practical issues in diagnosis and management;Mancini;Can J Cardiol,2017

2. CardioDiabetes: core competencies for cardiovascular clinicians in a rapidly evolving era of type 2 diabetes management;Mancini;Can J Cardiol,2018

3. Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update;Lipscombe;Can J Diabetes,2020

4. Pharmacologic glycemic management of type 2 diabetes in adults: 2020 update - the user’s guide;Senior;Can J Diabetes,2020

5. CCS/CHFS heart failure guidelines: clinical trial update on functional mitral regurgitation, SGLT2 inhibitors, ARNI in HFpEF, and tafamidis in amyloidosis;O’Meara;Can J Cardiol,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies;Trends in Endocrinology & Metabolism;2024-08

2. Adiposity, type 2 diabetes and atherosclerotic cardiovascular disease risk: Use and abuse of the body mass index;Atherosclerosis;2024-07

3. 2023 Guideline for the management of hypertension in the elderly population in China;Journal of Geriatric Cardiology;2024-06

4. GLP-1 receptor agonists and atherosclerosis protection: the vascular endothelium takes center stage;American Journal of Physiology-Heart and Circulatory Physiology;2024-05-01

5. Effectiveness and safety of the combination of sodium–glucose transport protein 2 inhibitors and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of observational studies;Cardiovascular Diabetology;2024-03-18